These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 6855551)

  • 1. [Cardiac glycosides and their use in daily general practice].
    Gaul G
    Med Welt; 1983 Apr; 34(14):452-5. PubMed ID: 6855551
    [No Abstract]   [Full Text] [Related]  

  • 2. [Indications and contraindications for therapy with cardiac glycosides].
    Haasis R
    Fortschr Med; 1982 Aug; 100(31-32):1436-9. PubMed ID: 7129303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of cardiac insufficiency with cardiac glycosides].
    Tsyganiĭ AA; Rudenko AF; Kovalev NL; Malinovskiĭ OP; Koziar VV
    Vrach Delo; 1980 Aug; (8):60-3. PubMed ID: 7415132
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of congestive heart failure with cardiac glycosides. I. New theses in the principles of treatment].
    Tomov I
    Vutr Boles; 1980; 19(6):7-14. PubMed ID: 7210653
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of chronic cardiac insufficiency with cardiac glycosides].
    Bonelli J
    Wien Med Wochenschr; 1982 Oct; 132(19):442-9. PubMed ID: 7179995
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of cardiac insufficiency 1].
    Breithaupt H
    Med Welt; 1979 Aug; 30(35):1249-54. PubMed ID: 530055
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biochemical principles of the effect of digitalis glycosides].
    Erdmann E
    Verh Dtsch Ges Herz Kreislaufforsch; 1982; 48():7-18. PubMed ID: 6314693
    [No Abstract]   [Full Text] [Related]  

  • 8. [Usefulness of left ventricular contraction period determination by the polygraphic method in the treatment of patients with overt circulatory failure by means of administering cardiac glycosides].
    Smielak-Korombel W
    Pol Tyg Lek; 1976 Sep; 31(38):1641-4. PubMed ID: 980985
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacologic basis of cardiotonic glucoside therapy].
    Imbs JL
    Cardiology; 1980; 65 Suppl 1():1-8. PubMed ID: 7379062
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacology of positive inotropically acting drugs].
    Scholz H
    Verh Dtsch Ges Herz Kreislaufforsch; 1982; 48():98-114. PubMed ID: 7187167
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of heart failure in hypertension].
    Linss G; Scholze J
    Z Arztl Fortbild (Jena); 1985; 79(17):727-32. PubMed ID: 2932861
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical application of inotropic drugs.
    Counihan TB
    Eur Heart J; 1982 Dec; 3 Suppl D():143-7. PubMed ID: 7160398
    [No Abstract]   [Full Text] [Related]  

  • 13. [Behavior of some intervals constituting ventricular systole during measured work in patients with cardiac insufficiency treated with cardiokinetic drugs].
    Iannetti M; Martini U; Caponnetto S
    Minerva Med; 1966 May; 57(43 Suppl):1991-4. PubMed ID: 5943257
    [No Abstract]   [Full Text] [Related]  

  • 14. [The clinical use of a new cardioactive glycoside: proscillaridin A].
    Maiorano G; Arbore S
    Minerva Med; 1967 Dec; 58(96):4243-6. PubMed ID: 6083285
    [No Abstract]   [Full Text] [Related]  

  • 15. [Contribution to the konwledge of some effects of proscillaridin on the cardiovascular system. Electrocardiographic and radiocardiographic research].
    Sorrentino F; Musco A; Cascone O; Modica G
    Clin Ter; 1966 Jul; 38(1):39-48. PubMed ID: 5990470
    [No Abstract]   [Full Text] [Related]  

  • 16. A preliminary report on a clinical trial of peruvoside--a new cardiac glycoside.
    Dalal NJ; Billimoria AR; Vakil NJ; Shah SJ
    Indian Heart J; 1972 Apr; 24(2):129-33. PubMed ID: 4637593
    [No Abstract]   [Full Text] [Related]  

  • 17. [The therapy of cardiac insufficiency using Theo-Alvonal].
    Kettermann W
    Munch Med Wochenschr; 1968 Jan; 110(4):228-32. PubMed ID: 5695033
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical use of a new cardioactive glycoside: proscillaridin A. Case studies].
    Pagliara R
    Minerva Med; 1967 Dec; 58(96):4296-301. PubMed ID: 6081717
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological aspects on the treatment of CHF.
    Andersson KE
    Acta Med Scand Suppl; 1981; 652():69-91. PubMed ID: 6120616
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical evaluation of the cardiotonic effects of proscilaridine].
    Netto MP; Forti N; Formicola A; Chryssovergis G; Zillioto EE; Campanari JC; Lunardi W; Giannini SD
    Rev Hosp Clin Fac Med Sao Paulo; 1973; 28(6):300-4. PubMed ID: 4767562
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.